Results 1 to 10 of about 8,732 (157)

Invasive meningococcal disease [PDF]

Arquivos de Neuro-Psiquiatria, 2013
Invasive meningococcal disease (IMD) is a major public health and continues to cause substantial mortality and morbidity. Serotype C is the most frequent in Brazil.
Vanessa L. Strelow, Jose E. Vidal
doaj   +6 more sources

Invasive meningococcal disease and travel

Journal of Infection and Public Health, 2010
Summary: The epidemiology of invasive meningococcal disease varies geographically and in time and the risk of acquiring the disease varies regionally, as well as with living conditions and behavior.
Ziad A. Memish, Anette Goubeaud, Michael Bröker, Claudius Malerczyk, Atef M. Shibl   +4 more
doaj   +3 more sources

Preventing invasive meningococcal disease in early infancy

Human Vaccines & Immunotherapeutics, 2022
This review considers the pathogenesis, diagnosis, and epidemiology of invasive meningococcal disease in infants, to examine and critique meningococcal disease prevention in this population through vaccination.
Jessica Presa, Lidia Serra, Catherine Weil-Olivier, Laura York   +3 more
doaj   +3 more sources

Impact of Meningococcal B Vaccine on Invasive Meningococcal Disease in Adolescents

Clinical Infectious Diseases, 2021
Abstract Background From 2017, a statewide cluster randomized trial was conducted in South Australia to assess the impact of the meningococcal B vaccine 4CMenB on pharyngeal Neisseria meningitidis carriage in adolescents.
Mark McMillan, Thomas Sullivan, Bing Wang   +2 more
exaly   +3 more sources

Postmortem Diagnosis of Invasive Meningococcal Disease

Emerging Infectious Diseases, 2014
We diagnosed invasive meningococcal disease by using immunohistochemical staining of embalmed tissue and PCR of vitreous humor from 2 men in New York City.
Alison D. Ridpath, Tanya A. Halse, Kimberlee A. Musser, Danielle Wroblewski, Christopher D. Paddock, Wun-Ju Shieh, Melissa Pasquale-Styles, Irini Scordi-Bello, Paula E. Del Rosso, Don Weiss   +9 more
doaj   +3 more sources

Critical appraisal of a quadrivalent CRM197 conjugate vaccine against meningococcal serogroups A, C W-135 and Y (Menveo®) in the context of treatment and prevention of invasive disease

Infection and Drug Resistance, 2011
Michael Bröker, Brian Cooper, Lisa M DeTora, Jeffrey J StoddardGlobal Medical Affairs, Novartis Vaccines and Diagnostics, Marburg, Germany, and Cambridge, MA, USAAbstract: Worldwide, invasive meningococcal disease affects about 500,000 people ...
Bröker M, Cooper B, DeTora LM, Stoddard JJ   +3 more
doaj   +2 more sources

A Decade of Invasive Meningococcal Disease Surveillance in Poland

PLoS ONE, 2013
Neisseria meningitidis is a leading etiologic agent of severe invasive disease. The objective of the study was to characterise invasive meningococcal disease (IMD) epidemiology in Poland during the last decade, based on laboratory confirmed cases.The study encompassed all invasive meningococci collected between 2002 and 2011 in the National Reference ...
Alicja Kuch, Izabela Waśko, Aleksandra Kozińska   +2 more
exaly   +5 more sources

Risk of Invasive Meningococcal Disease in Preterm Infants. [PDF]

Open Forum Infect Dis
Abstract Background Invasive meningococcal disease (IMD) is most common in the first year of life. We hypothesized that preterm infants may have a higher risk of IMD and more severe disease than term infants.
Calvert A, Campbell H, Heath PT, Jones CE, Le Doare K, Mensah A, Ladhani S.   +6 more
europepmc   +5 more sources

Invasive meningococcal disease and genome databases [PDF]

The Lancet Microbe, 2021
Jens Karlsson, Hannes Eichner, Edmund Loh   +2 more
doaj   +3 more sources

Invasive Meningococcal Disease, Utah, 1995–2005

Emerging Infectious Diseases, 2007
Trends in invasive meningococcal disease in Utah during 1995–2005 have differed substantially from US trends in incidence rate and serogroup and age distributions.
Rachelle B. Boulton, Stephen C. Alder, Susan Mottice, A. Peter Catinella, Carrie L. Byington   +4 more
doaj   +3 more sources